Pseudocompact-type growth and conversion of growth types of strains of Staphylococcus aureus in vitro and in vivo.

Journal of Bacteriology
K YoshidaY Takeuchi

Abstract

Some strains of Staphylococcus aureus grew as compact colonies in Brain Heart Infusion-serum-soft agar but as diffuse colonies in a modified Staphylococcus 110-serum-soft agar. These strains were designated "pseudocompact." Strains showing compact-type colonial morphology in both media were designated "compact," whereas strains showing diffuse-type growth in both media were designated "diffuse." It was observed that the most recently isolated strains of S. aureus were of the pseudocompact type, whereas most stock culture strains tested were of the compact type. Using cultures recently isolated from clinical material, it was shown that pseudocompact strains convert to compact-type growth after prolonged incubation. Interconversion of compact, diffuse, and pseudocompact growth forms could be induced in vitro by appropriate cultural conditions, and conversion of growth type was also observed in vivo. Femoral abscesses produced in mice by four different compact-type strains showed conversion to diffuse or pseudocompact-type growth during the course of the infection.

References

Jul 23, 1965·Annals of the New York Academy of Sciences·M G Koenig, M A Melly
Mar 1, 1968·Journal of Bacteriology·B B Wiley, N H Maverakis
Mar 1, 1958·Journal of Bacteriology·R A FINKELSTEIN, S E SULKIN
Nov 1, 1962·The Journal of Experimental Medicine·M G KOENIGD E ROGERS
Nov 1, 1962·The Journal of Experimental Medicine·M G KOENIGD E ROGERS
Mar 1, 1964·The Journal of Hygiene·C BARBER
Feb 1, 1962·The Journal of Experimental Medicine·S I MORSE

❮ Previous
Next ❯

Citations

Mar 1, 1984·Journal of Dairy Science·K YoshidaW B Evans
Jul 1, 1973·Japanese Journal of Microbiology·K Yoshida, M Takahashi
Feb 1, 1979·The Journal of Applied Bacteriology·K YoshidaC L San Clemente
Oct 1, 1972·Infection and Immunity·U ForsumE Hjelm
Nov 1, 1971·Infection and Immunity·K YoshidaY Naito
Jul 1, 1985·Journal of Clinical Microbiology·M ChomaratK Yoshida
Nov 1, 1970·Infection and Immunity·K Yoshida, Y Takeuchi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.